New incubator biotope by VIB launches to support biotech startup teams on their journey to success Ghent, Belgium, 24 March 2022 – Incubator program biotope by VIB launches today to support biotech startup teams looking to impact people’s lives through […] March 24, 2022 · Turnstone Communications
Qbic announces first close of new fund at EUR 49 million to invest in spin-offs from world-class knowledge partners St-Denijs-Westrem, Belgium, 17 March 2022 – Qbic, an inter-university venture capital fund focusing on the transformation of technological breakthroughs into […] March 17, 2022 · Turnstone Communications
Antimicrobial Resistance – the hidden killer we’re ignoring Antimicrobial Resistance has become an enormous challenge for global health, yet remains largely ignored by companies. As this deadly race […] March 16, 2022 · V-Bio Ventures
Abscint labels antibodies with radioactive material to spot harmful cells Abscint is one of several Belgian biotech companies using single-domain antibodies. But unlike the others, Abscint is using these antibodies […] March 16, 2022 · BioVox
Eye implant from iSTAR Medical keeps glaucoma under control Glaucoma is the leading cause of irreversible blindness, affecting around 100 million people worldwide. Good news though: the innovative implant […] March 16, 2022 · BioVox
RE-Place project: Reducing animal research through alternative methods If scientists could stop animal testing, most would do so immediately. So why is it taking so long to develop […] March 16, 2022 · SciMingo
V-Bio Ventures’ Portfolio Company Precirix raises EUR 80 million in Series B to advance its pipeline of precision radiopharmaceuticals Ghent, Belgium, 16 March 2022 – V-Bio Ventures today announced the completion of a EUR 80 million Series B round […] March 16, 2022 · V-Bio Ventures
flanders.healthTech launches 14 unique innovation projects in healthcare Ghent, Belgium, 10 March 2022 – Following the launch of the cluster flanders.healthTech in 2021, the first round of 14 […] March 10, 2022 · Turnstone Communications
V-Bio Ventures’ Portfolio Company Syndesi Therapeutics Acquired by AbbVie to Strengthen its Neuroscience Portfolio Ghent, Belgium, 1 March 2022 – V-Bio Ventures today announced the completion of the acquisition of its portfolio company Syndesi […] March 1, 2022 · V-Bio Ventures
miDiagnostics ultra-fast COVID-19 PCR Test succeeds in Brussels Airport pilot study Leuven, Belgium, 17 February 2022 – miDiagnostics, a fast-growing POC diagnostics company backed by Belgian Family Offices, announces the success of the […] February 17, 2022 · Turnstone Communications
SciMingo SciComm Academy launches spring program of workshops and lectures The next couple of months, researchers can take part in science communication workshops organized by SciMingo, such as popular science […] February 16, 2022 · SciMingo
Imitating nature: H2WIN’s innovative solution enables production of green hydrogen Belgian GreenTech company H2WIN has developed H2GREEN: an ingenious system to make hydrogen production 100% renewable, more efficient, less expensive, […] February 16, 2022 · BioVox
CRISPR takes the ‘bitter’ out of Belgian endives and chicory Researchers have identified the bitter substances in Belgian endives and chicory. Using the gene-editing technique CRISPR/Cas9, they have also succeeded […] February 16, 2022 · BioVox
Listening to chaos: could you control a hearing aid with your brain? February 16, 2022 · SciMingo